Anne Talkington

Anne Talkington, PhD, is an Assistant Professor at the University at Buffalo School of Pharmacy & Pharmaceutical Sciences, where she develops multiscale mathematical models at the intersection of immunology, oncology, and pharmacology to optimize cancer therapies.

• Education: PhD in Computational Biology (UNC Chapel Hill), MS in Applied Mathematics (UNC Chapel Hill), BS in Mathematics (Duke), BA in Biology (Duke)

Her research focuses on tumor-immune interactions, spatiotemporal immune activity, and immune checkpoint inhibition optimization, with expertise in in silico drug testing and pharmacokinetic modeling. Recent publications demonstrate trends in PEG immunogenicity mitigation, PBPK modeling, and computational immunotherapy optimization.

• Scientific Awards: National Research Council Fellowship (2023), P.E.O. Scholar Award (2020), NSF Graduate Fellowship (2016), MCM Meritorious Recognition (2013)

The Talkington Lab integrates mathematical modeling with experimental data to predict optimal treatment strategies for cancer immunotherapy, emphasizing spatial-temporal dynamics in the tumor microenvironment.